시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 소비자 직접 의뢰(DTC) 실험실 검사 시장 보고서(2025년)
Direct-To-Consumer (DTC) Laboratory Testing Global Market Report 2025
상품코드 : 1825707
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

소비자 직접 의뢰(DTC) 실험실 검사 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 연평균 복합 성장률(CAGR) 27.5%로 성장할 전망이며, 152억 8,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 질병의 신속하고 정확한 진단에 대한 수요 증가, 웰빙 및 예방 헬스케어의 중요성 증가, 신속한 현장 진단 검사에 대한 수요 증가, 감염성 아웃 브레이크 증가, 원격 의료 등장 등에 기인할 것으로 예측됩니다. 예측 기간 주요 동향으로는 차세대 시퀀서(NGS)의 통합, RNA 검출 및 분석, 싱글셀 PCR 분석, 바이오인포매틱스 소프트웨어 및 데이터 분석 툴, 마이크로플루이딕스 기술, 랩 칩 시스템, 포인트 오브 케어 검사(POCT), 인공지능(AI) 및 데이터 분석 등이 있습니다.

향후 5년간의 성장률 27.5%라고 하는 예측은 이 시장 전회 예측으로부터 0.5%라고 하는 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 관세 장벽은 폴란드와 일본에서 수입되는 가정용 HbA1c 및 지질 패널 수집 장치의 비용을 증가시키고, 예방 모니터링에 대한 접근을 감소시키며, 소비자 비용을 증가시킴으로써 미국의 원격 의료 시장을 방해할 것으로 예측됩니다. 이 영향은 또한 상호관세와 무역 긴장 증가 및 제한 증가로 인한 세계 경제와 무역에 대한 부정적인 영향으로 더욱 널리 느껴질 것으로 보입니다.

감염증 증가는 향후 소비자 직접 의뢰(DTC) 실험실 검사 시장의 성장을 이끌 것으로 예측됩니다. 감염은 박테리아, 바이러스, 기생충, 곰팡이와 같은 유해한 미생물로 인한 질병으로, 직접 또는 간접적인 접촉, 또는 곤충이나 동물과 같은 매개 동물을 통해 사람에서 사람으로 퍼집니다. 감염의 발생률은 생물학적, 환경적, 사회적, 경제적 요인의 조합에 의해 형성됩니다. DTC 실험실 검사는 검사 접근을 확대하고 조기 개입을 촉진하며 데이터 수집과 의식 향상을 통해 공중 보건 이니셔티브를 지원함으로써 이러한 질병의 예방, 발견 및 관리에 중요한 역할을 수행합니다. 예를 들어, 2024년 8월 영국 건강안전보장국(UKHSA)은 2023년 잉글랜드에서 368건의 홍역 환자가 발생했다고 보고했는데, 이는 2022년 53건에서 약 7배로 증가했으며 웨스트미드랜즈와 런던이 각각 44%와 33%를 차지했습니다. 그 결과 감염증의 유행 확대가 DTC 실험실 검사 시장 확대에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Direct-to-consumer (DTC) laboratory testing involves a model wherein individuals directly order medical tests and receive their results, bypassing traditional healthcare providers or intermediaries. This model typically operates through online platforms or services, allowing consumers to choose from a range of available tests, place orders, provide specimens either at home or at designated collection sites, and subsequently receive results electronically.

The primary samples used in direct-to-consumer (DTC) laboratory testing include blood, urine, saliva, and others. Blood samples involve small amounts of blood collected for medical testing or analysis, encompassing various tests such as genetic testing, disease risk assessment testing, complete blood count (CBC), diabetes testing, thyroid-stimulating hormone (TSH) testing, among others. These tests find applications in diagnostics, research and development, and drug discovery and development, and are utilized by end-users including hospitals, clinics, specialty labs, and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The direct-to-consumer (DTC) laboratory testing research report is one of a series of new reports from The Business Research Company that provides direct-to-consumer (DTC) laboratory testing market statistics, including the direct-to-consumer (DTC) laboratory testing industry's global market size, regional shares, competitors with a direct-to-consumer (DTC) laboratory testing market share, detailed direct-to-consumer (DTC) laboratory testing market segments, market trends and opportunities, and any further data you may need to thrive in the direct-to-consumer (DTC) laboratory testing industry. This direct-to-consumer (DTC) laboratory testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The direct-to-consumer (dtc) laboratory testing market size has grown exponentially in recent years. It will grow from $4.45 billion in 2024 to $5.78 billion in 2025 at a compound annual growth rate (CAGR) of 30.0%. The growth in the historic period can be attributed to growing prevalence of infectious and chronic diseases, increasing geriatric population, increasing use of miniaturized portable instruments, growing use of biomarker profiling, and growing demand for personalized medicine.

The direct-to-consumer (dtc) laboratory testing market size is expected to see exponential growth in the next few years. It will grow to $15.28 billion in 2029 at a compound annual growth rate (CAGR) of 27.5%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing emphasis on wellness and preventive healthcare, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and rise of telemedicine. Major trends in the forecast period include next-generation sequencing (NGS) integration, RNA detection and analysis, single-cell PCR analysis, bioinformatics software and data analysis tools, microfluidic technologies, lab-on-a-chip systems, and point-of-care testing (POCT), artificial intelligence (AI) and data analytics.

The forecast of 27.5% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. telehealth market by increasing the cost of at-home HbA1c and lipid panel collection devices imported from Poland and Japan, thereby reducing preventive monitoring access and elevating consumer costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing occurrence of infectious diseases is expected to drive the growth of the direct-to-consumer (DTC) laboratory testing market in the future. Infectious diseases are illnesses caused by harmful microorganisms like bacteria, viruses, parasites, or fungi, which spread from person to person through direct or indirect contact, or via vectors such as insects or animals. The rate of infectious diseases is shaped by a combination of biological, environmental, social, and economic factors. DTC laboratory testing plays a key role in preventing, detecting, and managing these diseases by expanding access to testing, encouraging early intervention, and supporting public health initiatives through data collection and awareness. For example, in August 2024, the UK Health Security Agency (UKHSA) reported 368 measles cases in England in 2023, a nearly sevenfold increase from 53 cases in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. As a result, the growing prevalence of infectious diseases is fueling the expansion of the DTC laboratory testing market.

Key players in the DTC laboratory testing market are actively developing innovative solutions, such as mobile phlebotomy services, to improve convenience and accessibility for their customers. Mobile phlebotomy services entail bringing blood collection (phlebotomy) to the patient's location, typically their home or workplace, eliminating the need for patients to visit medical facilities for blood tests. For example, in July 2023, Quest Diagnostics Incorporated, a US-based company specializing in diagnostic testing and services, introduced Quest Mobile, a new service designed to simplify the specimen collection process for laboratory testing nationwide. Quest Mobile enables patients to conveniently schedule appointments for at-home specimen collection by skilled phlebotomists. This user-friendly option allows patients to undergo various laboratory tests from the comfort of their homes, ensuring ease and accessibility in the testing process.

In May 2023, Getlabs, a US-based provider of at-home diagnostic collections, collaborated with Nice Healthcare to enhance access to in-home healthcare services and lab testing. This strategic partnership aims to streamline the overall healthcare experience for individuals by leveraging the combined strengths of both entities. Nice Healthcare, a US-based provider of in-home and virtual primary care services, complements Getlabs' offerings, further expanding access to essential healthcare services and lab testing for individuals.

Major companies operating in the direct-to-consumer (DTC) laboratory testing market are Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, PerkinElmer Inc, Genesis Healthcare Co., Natera Inc, Sonora Quest Laboratories, Ancestry.com LLC, 23andMe Holding Co, Thorne HealthTech Inc, Metropolis Healthcare Limited, Color Health Inc, LetsGetChecked Inc., MyHeritage Ltd, Everlywell Inc, Complete Genomics Incorporated, DanteLabs Inc, Gene by Gene Ltd., Veritas Intercontinental, DirectLabs LLC., WellnessFX Inc, Ulta Lab Tests LLC, Any Lab Test Now Inc, Vitagene Inc.

North America was the largest region in the direct-to-consumer (DTC) laboratory testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the direct-to-consumer (DTC) laboratory testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the direct-to-consumer (DTC) laboratory testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The direct-to-consumer (DTC) laboratory testing market consists of revenues earned by entities by provide services such as accessibility, convenience, wellness screening, genetic testing, health monitoring, nutritional analysis, fitness and performance testing, ancestry testing, maternity testing, pharmacogenomics testing, and nutrigenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The direct-to-consumer (DTC) laboratory testing market also includes sales of home test kits, sample collection kits, point-of-care testing devices, sequencing kits, automated liquid handling systems, thermal cyclers, sterile swabs, wearable devices, and mobile apps or online platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Direct-To-Consumer (DTC) Laboratory Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on direct-to-consumer (dtc) laboratory testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for direct-to-consumer (dtc) laboratory testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The direct-to-consumer (dtc) laboratory testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Direct-To-Consumer (DTC) Laboratory Testing Market Characteristics

3. Direct-To-Consumer (DTC) Laboratory Testing Market Trends And Strategies

4. Direct-To-Consumer (DTC) Laboratory Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Direct-To-Consumer (DTC) Laboratory Testing Growth Analysis And Strategic Analysis Framework

6. Direct-To-Consumer (DTC) Laboratory Testing Market Segmentation

7. Direct-To-Consumer (DTC) Laboratory Testing Market Regional And Country Analysis

8. Asia-Pacific Direct-To-Consumer (DTC) Laboratory Testing Market

9. China Direct-To-Consumer (DTC) Laboratory Testing Market

10. India Direct-To-Consumer (DTC) Laboratory Testing Market

11. Japan Direct-To-Consumer (DTC) Laboratory Testing Market

12. Australia Direct-To-Consumer (DTC) Laboratory Testing Market

13. Indonesia Direct-To-Consumer (DTC) Laboratory Testing Market

14. South Korea Direct-To-Consumer (DTC) Laboratory Testing Market

15. Western Europe Direct-To-Consumer (DTC) Laboratory Testing Market

16. UK Direct-To-Consumer (DTC) Laboratory Testing Market

17. Germany Direct-To-Consumer (DTC) Laboratory Testing Market

18. France Direct-To-Consumer (DTC) Laboratory Testing Market

19. Italy Direct-To-Consumer (DTC) Laboratory Testing Market

20. Spain Direct-To-Consumer (DTC) Laboratory Testing Market

21. Eastern Europe Direct-To-Consumer (DTC) Laboratory Testing Market

22. Russia Direct-To-Consumer (DTC) Laboratory Testing Market

23. North America Direct-To-Consumer (DTC) Laboratory Testing Market

24. USA Direct-To-Consumer (DTC) Laboratory Testing Market

25. Canada Direct-To-Consumer (DTC) Laboratory Testing Market

26. South America Direct-To-Consumer (DTC) Laboratory Testing Market

27. Brazil Direct-To-Consumer (DTC) Laboratory Testing Market

28. Middle East Direct-To-Consumer (DTC) Laboratory Testing Market

29. Africa Direct-To-Consumer (DTC) Laboratory Testing Market

30. Direct-To-Consumer (DTC) Laboratory Testing Market Competitive Landscape And Company Profiles

31. Direct-To-Consumer (DTC) Laboratory Testing Market Other Major And Innovative Companies

32. Global Direct-To-Consumer (DTC) Laboratory Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Direct-To-Consumer (DTC) Laboratory Testing Market

34. Recent Developments In The Direct-To-Consumer (DTC) Laboratory Testing Market

35. Direct-To-Consumer (DTC) Laboratory Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기